NTLA-2002
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for NTLA-2002, covering 2025-11-28 to 2026-03-24. Get the full timeline:
Most recent: Clinical Trial Update: NTLA-2002 in Adults With Hereditary Angioedema (HAE) [Phase 1, Phase 2]